In­dia ap­proves spe­cial­ized cen­tre for derma clin­i­cal tri­als

BioSpectrum (Asia) - - REGULATORY NEWS -

In a first, the Drug Con­troller Gen­eral of In­dia (DCGI) have given ap­proval to a chain of der­ma­tol­ogy and plas­tic surgery cen­tres— The Es­thetic Clin­ics, for conducting clin­i­cal tri­als and drug de­vel­op­ment for skin, hair and other plas­tic surgery med­i­ca­tions, cos­me­tol­ogy and cos­metic surgery de­vices in In­dia.

The ini­tia­tive will help in the faster launch of newer, more in­no­va­tive, cos­metic, der­ma­tol­ogy and plas­tic surgery prod­ucts, while re­duc­ing cost in­volved in prod­uct test­ing. It will ben­e­fit In­dian phar­ma­ceu­ti­cal com­pa­nies by grant­ing them ac­cess to qual­ity re­search fa­cil­i­ties, clin­i­cians and lab­o­ra­to­ries in In­dia, with­out hav­ing to go over­seas, to con­duct the tri­als.

At present, clin­i­cal tri­als are not man­dated for ev­ery cos­metic prod­uct that en­ters In­dian mar­ket pro­vided it is ap­proved in other mar­kets. There are a few clin­i­cal tri­als that are con­ducted by clin­i­cal re­search or­gan­i­sa­tions in In­dia, but they do not have the clin­i­cal acu­men in cos­metic, plas­tic or aes­thetic seg­ment. Ma­jor­ity of clin­i­cal trial cen­tres work in phar­ma­ceu­ti­cal drug de­vel­op­ment, but not for cos­metic and aes­thetic solutions.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.